Senior Vice President, Corporate Development and General Counsel · Traws Pharma, Inc. (TRAW)

Abraham Oler

FY2021 is the first fiscal year CompBrief holds for Abraham Oler as a named executive officer of Traws Pharma; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$1,093,291

Salary $375,000Stock awards $383,588Bonus $139,875

3rd of 3 named executive officers at Traws Pharma by FY2021 total.

3 named officers on file for Traws Pharma, FY2021

Abraham Oler’s pay file — $29

  • 1 fiscal year of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Traws Pharma’s whole pay program stands against its peers

  • Traws Pharma’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on TRAW→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 29, 2022 (10-K).

Free

Get Abraham Oler’s full pay file as a PDF — free

More than this page: up to 10 years of Abraham’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Abraham Oler compensation by year

Traws Pharma Summary Compensation Table · the one fiscal year held
In US dollars, as Traws Pharma reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021
Salary$375,000
Bonus$139,875
Stock awards$383,588
Option awards$180,089
Non-equity incentive$0
Pension and deferred compensation$0
All other$14,739
Total$1,093,291

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Traws Pharma, Inc. 10-K filed April 29, 2022, accession 0001104659-22-053710, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Traws Pharma, Inc. filed document, accession 0001104659-22-053710. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2022.

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
PSU13,865$35,356—
RSU13,400$34,170—
Option330—$65.10
Option1,332—$4.65
Option11,759——
Option13,866——
Option40,000—$5.19

Per the Outstanding Equity Awards at Fiscal Year-End table in Traws Pharma, Inc.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it.

Traws Pharma’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Steven FruchtmanPresident and Chief Executive Officer$2,674,213
Mark GuerinChief Financial Officer$1,299,520
Abraham Oler · this pageSenior Vice President, Corporate Development and General Counsel$1,093,291

The full Traws Pharma compensation record

free company brief

This page is one person within Traws Pharma's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Traws Pharma's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Abraham Oler's compensation dossier · One-time report. No refunds.